Skip to main content
Pharmicell Co.,Ltd. logo

Pharmicell Co.,Ltd. — Investor Relations & Filings

Ticker · 005690 ISIN · KR7005690003 KO Manufacturing
Open in API
Filings indexed 275 across all filing types
Latest filing 2025-07-15 Major Shareholding Noti…
Country KR South Korea
Listing KO 005690

About Pharmicell Co.,Ltd.

https://www.pharmicell.com/eng/

Pharmicell Co., Ltd. is a biopharmaceutical company specializing in stem cell technology and advanced bio-based materials. The company is a pioneer in regenerative medicine, having developed Hearticellgram-AMI, the world's first approved stem cell therapy for acute myocardial infarction. Its core business includes the development of stem cell therapeutics, a stem cell banking service for adult and cord blood cells, and a line of cosmetics based on stem cell culture media. A significant division focuses on fine chemicals, manufacturing and supplying critical raw materials for the pharmaceutical industry, such as nucleosides, mPEGs, and oligonucleotides for gene therapies. The company also produces eco-friendly flame retardants for industrial use.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding collateral contracts (주식담보계약 변경). This type of filing is classified as a Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds and changes in control/collateral status.
2025-07-15 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement Classification · 100% confidence The document is a short announcement (741 characters) regarding the scheduling of an upcoming Investor Relations (IR) meeting (Non-Deal Roadshow). It provides the date, location, and purpose of the meeting, and directs readers to the company website to access the actual presentation materials. Per the 'Menu vs Meal' rule, since this is an announcement of an event/report rather than the presentation itself, it is classified as a Report Publication Announcement (RPA).
2025-07-08 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Pharmicell Co., Ltd. for the period ending March 31, 2025. It contains detailed financial data, business operations, management discussions, and capital structure information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-08 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal disclosure of a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) between Pharmicell and LG Chem. It details the contract value, duration, and terms. Since this is a specific announcement of a commercial contract and does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category for material corporate events.
2025-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of a specific executive (Kim Hyun Soo) of Pharmicell Co., Ltd. This type of filing is a standard regulatory requirement for insider trading or changes in executive shareholdings, which corresponds to the 'Director's Dealing' category.
2025-04-30 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Pharmicell. It details specific transactions (장내매수 - open market purchase) by a major shareholder (Kim Hyun-soo) and provides a summary of shareholding changes for the major shareholders group. This type of filing is a standard regulatory disclosure for significant shareholding changes, which falls under the 'Major Shareholding Notification' category.
2025-04-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.